<!DOCTYPE html>
<html lang="en">
<head>
     <meta charset="UTF-8">
     <title>Transformed Care for Advanced Medullary Thyroid Cancer: Incorporating the Right Treatments for the Right Patient at the Right Time</title>
</head>
<body>
  <table width="100%" cellpadding="0" cellspacing="0">
  <tr>
  <td align="center">
    <table width="600" cellspacing="0" cellpadding="0" border="0">
<!-- header -->
    <tr>
      <td align="center">
        <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#4c4c4c;vertical-align:middle; margin-bottom: 10px;">
          <img src="https://i1.createsend1.com/ei/d/B7/A7A/B9C/024117/csimport/prime_0.png" alt="prIME Oncology" border="0" style="vertical-align:middle; margin-right: 12px; margin-bottom:15px" />professional • independent • medical • education
        </p>
      </td>
    </tr>
          <tr>
      <td><img src="http://development.primeoncology.org/~/media/Images/Activity/2014/ASH/cml1/banner.ashx?w=936" width="610" border="0" style="display:block;" alt="Clinical Spotlight in Chronic Myeloid Leukemia From the 2014 Annual Hematology Meeting in San Francisco"/></td>
    </tr>
    
<!-- content -->
      <tr>
        <td style="border-right:solid #000453 7px; border-left:solid #000453 7px;" align="center">
 
 
                <!-- Inner Content Table -->
           <table cellspacing="0" width="580" style="border: 20px solid #fff; table-layout: fixed;" border="0">
            <tr>
              <td>
                <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin:0; padding: 0;display:inline;">
                Clinical Spotlight in Chronic Myeloid Leukemia From the 2014 Annual Hematology Meeting in San Francisco</h2>
                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                  View a CME-certified expert discussion, eNewsflash, and downloadable slides focused on emerging data on the management of CML resistant to standard therapies presented at the 2014 Annual Hematology Meeting in San Francisco.
                </p>
                <p style="font-size: 14px; font-family: arial,helvetica,sans-serif;
                color: #4c4c4c; width: 150px;">&raquo;<a href="http://www.primeoncology.org/online_education/heme/2014/2014cml_sanfrancisco_csp.aspx" style="text-decoration:none;" target="_blank"> <strong>View Activity</strong></a></p>
                <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#ccc; text-align:center;">
                     ___________________________________________________________</p>
                    
                <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin-bottom:15px">Activity Features</h2>
               <br>
                <table cellspacing="0" cellpadding="0" border="0" width="100%">
                  <tr>
                    <td valign="top">
                      <table cellpadding="0" cellspacing="6" border="0">
                        <tr>
                          <td><img src="http://www.primeoncology.org/Presentation/Onco/assets/images/icons/Discussion.png" alt="icon" width="32" height="32" border="0"></td>
                          <td><h5 style="font-family:Arial, Helvetica, sans-serif;color:#666; padding: 0;margin: 0;font-size:12px;display: inline-block;height: 22px;vertical-align: middle;">Expert Discussion</h5></td>
                        </tr>
                        <tr>
                          <td><img src="http://www.primeoncology.org/Presentation/Onco/assets/images/icons/newsflash.png" alt="icon" width="32" height="32" border="0"></td>
                          <td><h5 style="font-family:Arial, Helvetica, sans-serif;color:#666; padding: 0;margin: 0;font-size:12px;display: inline-block;height: 22px;vertical-align: middle;">NewsFlash</h5></td>
                        </tr>
                         <tr>
                          <td><img src="http://www.primeoncology.org/Presentation/Onco/assets/images/icons/Download.png" alt="icon" width="32" height="32" border="0"></td>
                          <td><h5 style="font-family:Arial, Helvetica, sans-serif;color:#666; padding: 0;margin: 0;font-size:12px;display: inline-block;height: 22px;vertical-align: middle;">Downloadable Slides</h5></td>
                        </tr>
                        <tr>
                          <td><img src="http://www.primeoncology.org/Presentation/Onco/assets/images/icons/cme.png" alt="icon" width="32" height="32" border="0"></td>
                          <td><h5 style="font-family:Arial, Helvetica, sans-serif;color:#666; padding: 0;margin: 0;font-size:12px;display: inline-block;height: 22px;vertical-align: middle;">CME-Certified</h5></td>
                        </tr>
                      </table>
                    </td>
                    <td colspan="2" align="center">
                      <img src="http://development.primeoncology.org/online_education/heme/2014/~/media/Images/Activity/2014/ASH/cml1/cml1.ashx" alt="preview" width="330" height="230" border="0" style="border-style:none;">
                    </td>
                  </tr>
                </table>
                 <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#ccc; text-align:center;">
                     ___________________________________________________________</p>
                    
                <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin-bottom:15px">Activity Abstracts</h2>
                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;"><strong> Abstract #3135:</strong> 
                  <br>Long-Term Follow-Up of Ponatinib Efficacy and Safety in the Phase 2 PACE Trial</p>
                  <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;"><strong>Abstract #518:</strong> <br>
                    Achieving Early Landmark Response Is Predictive of Outcomes in Heavily Pretreated Patients with Chronic Phase Chronic Myeloid Leukemia (CP-CML) Treated With Ponatinib</p>

                <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#ccc; text-align:center;">
                     ___________________________________________________________</p>
                    
                <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin-bottom:15px">Faculty</h2>
                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                  <strong>Martin C. Müller, MD</strong> <br>
                  Universitätsmedizin Mannheim<br>
                   Mannheim, Germany<br>
                </p>
                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                  <strong>Neil P. Shah, MD, PhD</strong> <br>
                  University of California San Fransisco<br>
                  San Fransisco, California, United States<br>
                </p>
                 <p style="font-size: 14px; font-family: arial,helvetica,sans-serif;
                color: #4c4c4c; width: 150px;">&raquo;<a href="http://www.primeoncology.org/online_education/heme/2014/2014cml_sanfrancisco_csp.aspx" style="text-decoration:none;" target="_blank"> <strong>View Activity</strong></a></p>

                 <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#ccc; text-align:center;">
                     ___________________________________________________________</p>
              
              
                <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin-bottom:15px">Provider</h2>
              
                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">This activity is provided by prIME Oncology.</p>

                <div align="center"><img src="http://www.primeoncology.org/live_education/heme/~/media/Images/Sponsor/prime.ashx" alt="ACCME" width="112" height="66" /></div>

                 <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#ccc; text-align:center;">
                 ___________________________________________________________</p>

                 <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin-bottom:15px">Continuing Education</h2>
                
                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">prIME Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME<sup>&copy;</sup>) to provide continuing medical education for physicians.</p>
                
                <div align="center"><img src="http://www.primeoncology.org/online_education/solid_tumor/2013/~/media/Images/Sponsor/small_logos/accme.ashx" alt="ACCME" width="112" height="66" /></div>
                     
                <p colspan="3" style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">prIME Oncology designates this enduring activity for a maximum of xx<em> AMA PRA Category 1 Credits™</em>. Physicians should claim only the credit commensurate with the extent of their participation in the activity.</p>
              
                <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#ccc; text-align:center;">
                 ___________________________________________________________</p>
                 
                 
                <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin-bottom:10px">Support</h2>
                  
                <p colspan="3" style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">This educational activity is supported by a grant from ARIAD Pharmaceuticals Inc.</p>

                 <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#ccc; text-align:center;">
                 ___________________________________________________________</p>
                 

                  <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin-bottom:10px">Other prIME Activities</h2>
                  
                <table cellpadding="0" cellspacing="5" border="0" align="center">
                  <tr valign="top">
                    <td align="center">
                      <a style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4C4C4C; text-decoration:none" href="http://www.primeoncology.org/online_education/heme/2014/2014_sanfrancisco_dcu.aspx">
                      <img src="http://www.primeoncology.org/~/media/Images/Activity/2011/ASH/DCU/thumb.ashx" alt="online activity" style="border-style:none" /><br/>
                       Daily Clinical Updates: Up-to-Date Highlights from the 2014 Annual Hematology Meeting in San Francisco
                      </a>
                    </td>
                    
                    <td align="center">
                      <a style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4C4C4C; text-decoration:none" href="http://www.primeoncology.org/online_education/heme/2014/2014-cml-blog.aspx">
                      <img src="http://www.primeoncology.org/~/media/Images/Activity/2011/community_opinion/thumb.ashx" alt="online activity" style="border-style:none" /><br/>
                      CommunityOpinion: CML Discussion with Elias Jabbour, MD</a>
                    </td>
                    
                    <td align="center">
                      <a style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4C4C4C; text-decoration:none" href="http://www.primeoncology.org/online_education/heme/2014/cml-obrien.aspx">
                      <img src="http://www.primeoncology.org/online_education/~/media/Images/Activity/Interactive%20Clinical%20scenario/listing%20image.ashx" alt="online activity" style="border-style:none" /><br/>
                      InterActive Clinical Scenario: Late Milestones and Treatment Discontinuation in Patients with CML</a>
                    </td>
                  </tr>
                </table>
                <br>
              </td>
            </tr>
           </table><!-- //Inner Content Table -->
     
 
        </td>
      </tr>
<!--       footer -->
      <tr style="background-color: #666666;">
        <td  style="border-right:solid #000453 7px; border-left:solid #000453 7px;border-bottom:solid #000453 7px;">
        <table width="100%" border="0" cellspacing="0" cellpadding="0">
            <tr>
              <td align="center">
                <table cellpadding="0" cellspacing="0" style="color: #fff; padding: 30px 10px 10px 30px; font-family:Arial, Helvetica, sans-serif;font-size: 12px; font-weight: normal;" border="0">
                  <tr valign="top">
                    <td style="padding-right: 6px;" align="right">
                       <img src="http://www.primeoncology.org/~/media/Images/Image%20Links/mobile.ashx" alt="icon" width="32" height="32" border="0" />
                    </td>
                    <td style="padding-bottom: 15px;">
                       <strong>Get the prIME Oncology app</strong><br />
                       <a style="color: #fd8332; text-decoration: none; font-weight: bold;" href="https://itunes.apple.com/us/app/prime-oncology/id681001525?ls=1&mt=8">iPhone</a>
                       <span> | </span>
                       <a style="color: #fd8332; text-decoration: none; font-weight: bold;" href="https://play.google.com/store/apps/details?id=com.primeoncology.mobile&hl=en">Android</a>
                    </td>
                  </tr>
                </table>
              </td>
              <td align="center">
                <a style="padding-left: 10px;" href="https://plus.google.com/109069474896753641435"><img alt='google' src="http://www.primeoncology.org/~/media/Images/Image%20Links/google.ashx" /></a>
                <a style="padding-left: 10px;" href="https://twitter.com/prIME_Oncology"><img alt='twitter' src="http://www.primeoncology.org/~/media/Images/Image%20Links/twitter.ashx" /></a>
                <a style="padding-left: 10px;" href="http://www.youtube.com/user/prIMEOncologyUpdate"><img alt='youtube' src="http://www.primeoncology.org/~/media/Images/Image%20Links/youtube.ashx" /></a>
                <a style="padding-left: 10px;" href="http://www.facebook.com/pages/Prime-Oncology/364934120249753"><img alt='facebook' src="http://www.primeoncology.org/~/media/Images/Image%20Links/facebook.ashx" /></a>
                <a style="padding-left: 10px;" href="http://www.linkedin.com/company/prime-oncology/"><img alt='linkedin' src="http://www.primeoncology.org/~/media/Images/Image%20Links/linkedin.ashx" /></a></td>
            </tr>
            
            <tr>
              <td colspan="2" align="center">
                <table width="100%">
                  <tr>
                    <td width="36%" align="right">
                      <img hspace="15" src="http://primehc.org/email/images/logos/prime.png" alt="prIME Oncology" width="45" height="27" style="vertical-align: top;" border="0">
                    </td>
                    <td width="64%">
                      <p style="font-size: 10px;color: #bbb;font-family: Arial; text-align:left;">
                      Schenkkade 50 | Suite 16 | 2595 AR The Hague | the Netherlands<br>
                      2 Concourse Parkway | Suite 270 | Atlanta, Georgia | 30328 USA
                      </p>
                    </td>
                  </tr>
                </table>
              </td>
            </tr>
            <br>
          </table>
        </td>
      </tr>
    </table>
  </td></tr></table>
</body>
</html>

​